Choroidal Osteoma with Choroidal Neovascular Membrane treated with Anti- vascular Endothelial Growth Factor: A Rare Case with Review of Literatures

Authors

  • Phuntsho Dorji Gyalyum Kesang Choeden Wangchuck National Eye Centre, Thimphu, Bhutan
  • Nor Tshering Lepcha Gyalyum Kesang Choeden Wangchuck National Eye Centre, Thimphu, Bhutan
  • Raba Thapa Tilganga Institute of Ophthalmology, Kathmandu, Nepal

DOI:

https://doi.org/10.3126/nepjoph.v13i2.33218

Keywords:

Anti-vascular endothelial growth factor, Choroidal neovascular membrane, Choroidal osteoma

Abstract

Introduction: Choroidal osteoma, usually unilateral, is a rare benign tumor of choroid. It is predominantly seen in young females. 

Case: We report a case of a 35-year-old female with unilateral choroidal osteoma associated with choroidal neovascular membrane (CNVM). The diagnosis was confirmed with clinical examination, ocular ultrasonography, fundus fluorescein angiography and macular optical coherence tomography. Choroidal neovascular membrane improved with 3 doses of bevacizumab, an anti-vascular endothelial growth factors (Anti-VEGF).

Conclusion: Anti-VEGF monotherapy can be a cost effective primary modality of treatment for choroidal neovascular membrane secondary to choroidal osteoma.

Downloads

Download data is not yet available.
Abstract
356
PDF
536

Downloads

Published

2021-06-26

How to Cite

Dorji, P., Lepcha, N. T., & Thapa, R. (2021). Choroidal Osteoma with Choroidal Neovascular Membrane treated with Anti- vascular Endothelial Growth Factor: A Rare Case with Review of Literatures . Nepalese Journal of Ophthalmology, 13(2), 196–201. https://doi.org/10.3126/nepjoph.v13i2.33218

Issue

Section

Case Reports